# A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus

> **NCT06140485** · PHASE3 · UNKNOWN · sponsor: **Natural Wellness Egypt** · enrollment: 400 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** NW Low-Glu®
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06140485
- **Lead sponsor:** Natural Wellness Egypt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03
- **Primary completion:** 2025-09
- **Final completion:** 2025-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06140485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06140485, "A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06140485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*